| |
CDC Reports Disparities in PrEP USE: 'particularly Black and Hispanic/Latino men and women.'
|
| |
| |
Overall in 2022, 36% of the 1.2 million people who could benefit from PrEP were prescribed it, compared to 23% in 2019, the year that EHE was announced.
These data highlight the importance of focusing programs and policies to accelerate progress in prevention and treatment for disproportionately affected groups, particularly Black and Hispanic/Latino men and women.
While the preliminary data show improvement in PrEP prescriptions among all racial/ethnic groups from 2019 to 2022, the reach of this strategy is far from equal, and severe and widening inequities persist. Estimates suggest 94% of White people who could benefit from PrEP have been prescribed it, but only 13% of Black and 24% of Hispanic/Latino people who could benefit have been prescribed PrEP.
Today, as part of CDC’s quarterly HIV Surveillance Data Tables*, CDC published preliminary data on pre-exposure prophylaxis (PrEP) coverage. These preliminary data (Tables 3A-3C) indicate that in 2022, for the first time, more than one-third of people in the U.S. who could benefit from PrEP had been prescribed it. Increasing PrEP coverage is one of the key prevention strategies outlined in the Ending the HIV Epidemic in the U.S. (EHE) initiative.
https://www.cdc.gov/hiv/library/reports/surveillance-data-tables/vol-4-no-3/index.html?ACSTrackingID=FCP_24_USCDC_1046-DM115354&ACSTrackingLabel=[Proof 24] Preliminary data on Pre-Exposure Prophylaxis (PrEP) Coverage Released&deliveryName=FCP_24_USCDC_1046-DM115354
Deeply entrenched social determinants of health cause and exacerbate many of these disparities and their outcomes. Most new HIV infections in 2021 were among gay and bisexual men, the majority of whom were Black or Hispanic/Latino. About one-fifth of new HIV infections in 2021 were among women, and over half of those were among Black women.
|
|
| |
| |
|
|
|
